203 related articles for article (PubMed ID: 36311742)
1. Non-invasive measurement of tumor immune microenvironment and prediction of survival and chemotherapeutic benefits from
Li J; Zhang C; Guo H; Li S; You Y; Zheng P; Zhang H; Wang H; Bai J
Front Immunol; 2022; 13():1019386. PubMed ID: 36311742
[TBL] [Abstract][Full Text] [Related]
2. Radiomic signature of
Jiang Y; Yuan Q; Lv W; Xi S; Huang W; Sun Z; Chen H; Zhao L; Liu W; Hu Y; Lu L; Ma J; Li T; Yu J; Wang Q; Li G
Theranostics; 2018; 8(21):5915-5928. PubMed ID: 30613271
[TBL] [Abstract][Full Text] [Related]
3. Radiomics analysis of [
Li Y; Zhang Y; Fang Q; Zhang X; Hou P; Wu H; Wang X
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2599-2614. PubMed ID: 33416951
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer.
Jiang Y; Wang H; Wu J; Chen C; Yuan Q; Huang W; Li T; Xi S; Hu Y; Zhou Z; Xu Y; Li G; Li R
Ann Oncol; 2020 Jun; 31(6):760-768. PubMed ID: 32240794
[TBL] [Abstract][Full Text] [Related]
5. Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer.
Jiang Y; Chen C; Xie J; Wang W; Zha X; Lv W; Chen H; Hu Y; Li T; Yu J; Zhou Z; Xu Y; Li G
EBioMedicine; 2018 Oct; 36():171-182. PubMed ID: 30224313
[TBL] [Abstract][Full Text] [Related]
6.
Xue XQ; Yu WJ; Shi X; Shao XL; Wang YT
Front Oncol; 2022; 12():911168. PubMed ID: 36003788
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive Assessment of HER2 Expression Status in Gastric Cancer Using
Jiang X; Li T; Wang J; Zhang Z; Chen X; Zhang J; Zhao X
Cancer Biother Radiopharm; 2024 Apr; 39(3):169-177. PubMed ID: 38193811
[No Abstract] [Full Text] [Related]
8. Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer.
Jiang Y; Xie J; Huang W; Chen H; Xi S; Han Z; Huang L; Lin T; Zhao LY; Hu YF; Yu J; Cai SR; Li T; Li G
Cancer Immunol Res; 2019 Dec; 7(12):2065-2073. PubMed ID: 31615816
[TBL] [Abstract][Full Text] [Related]
9. Radiomics signature from [
Jiang C; Huang X; Li A; Teng Y; Ding C; Chen J; Xu J; Zhou Z
Eur Radiol; 2022 Aug; 32(8):5730-5741. PubMed ID: 35298676
[TBL] [Abstract][Full Text] [Related]
10. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer.
Chen D; Chen H; Chi L; Fu M; Wang G; Wu Z; Xu S; Sun C; Xu X; Lin L; Cheng J; Jiang W; Dong X; Lu J; Zheng J; Chen G; Li G; Zhuo S; Yan J
JAMA Netw Open; 2021 Nov; 4(11):e2136388. PubMed ID: 34846524
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Computed Tomography-Based Radiomics Signature to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
Wang W; Peng Y; Feng X; Zhao Y; Seeruttun SR; Zhang J; Cheng Z; Li Y; Liu Z; Zhou Z
JAMA Netw Open; 2021 Aug; 4(8):e2121143. PubMed ID: 34410397
[TBL] [Abstract][Full Text] [Related]
12. The value of
Ma J; Guo D; Miao W; Wang Y; Yan L; Wu F; Zhang C; Zhang R; Zuo P; Yang G; Wang Z
Abdom Radiol (NY); 2022 Apr; 47(4):1244-1254. PubMed ID: 35218381
[TBL] [Abstract][Full Text] [Related]
13. Radiographical Evaluation of Tumor Immunosuppressive Microenvironment and Treatment Outcomes in Gastric Cancer: A Retrospective, Multicohort Study.
Lin JX; Lin JP; Weng Y; Lv CB; Chen JH; Zhan CY; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Zhou WX; Zhang XJ; Zheng CH; Cai LS; Ma YB; Huang CM
Ann Surg Oncol; 2022 Aug; 29(8):5022-5033. PubMed ID: 35294651
[TBL] [Abstract][Full Text] [Related]
14.
Mi L; Zhao Y; Zhao X; Yin F; Yin X; Li N; Shi J; Han X; Duan X; Zhao M; Han G; Wang J
Cancer Biother Radiopharm; 2021 Oct; 36(8):662-671. PubMed ID: 32783634
[No Abstract] [Full Text] [Related]
15. Noninvasive imaging evaluation of peritoneal recurrence and chemotherapy benefit in gastric cancer after gastrectomy: a multicenter study.
Sun Z; Wang W; Huang W; Zhang T; Chen C; Yuan Q; Chen Y; Zhou K; Han Z; Feng H; Chen H; Liang X; Hu Y; Yu J; Liu H; Yu L; Xu Y; Li G; Jiang Y
Int J Surg; 2023 Jul; 109(7):2010-2024. PubMed ID: 37300884
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tumor metabolic imaging phenotype by FDG PET radiomics in HNSCC.
Yoon H; Ha S; Kwon SJ; Park SY; Kim J; O JH; Yoo IR
Ann Nucl Med; 2021 Mar; 35(3):370-377. PubMed ID: 33554314
[TBL] [Abstract][Full Text] [Related]
17. A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study.
Zhan PC; Yang S; Liu X; Zhang YY; Wang R; Wang JX; Qiu QY; Gao Y; Lv DB; Li LM; Luo CL; Hu ZW; Li Z; Lyu PJ; Liang P; Gao JB
BMC Cancer; 2024 Apr; 24(1):404. PubMed ID: 38561648
[TBL] [Abstract][Full Text] [Related]
18. Radiomic analysis for predicting prognosis of colorectal cancer from preoperative
Lv L; Xin B; Hao Y; Yang Z; Xu J; Wang L; Wang X; Song S; Guo X
J Transl Med; 2022 Feb; 20(1):66. PubMed ID: 35109864
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral and Peritumoral Radiomics of Contrast-Enhanced CT for Prediction of Disease-Free Survival and Chemotherapy Response in Stage II/III Gastric Cancer.
Li J; Zhang C; Wei J; Zheng P; Zhang H; Xie Y; Bai J; Zhu Z; Zhou K; Liang X; Xie Y; Qin T
Front Oncol; 2020; 10():552270. PubMed ID: 33425719
[TBL] [Abstract][Full Text] [Related]
20. Value of pre-therapy
Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
